News About: Pharm. Industry
Generic battle to be intensifying over Lipitor and Zocor
With many global makers' blockbuster products coming off patent, the race for generic statin market in Korea is set to be in full force this year.
The Korean statin market is estimated to be worth a massive 403.8 b...
Pharmaceutical stocks to draw attention
Pharmaceutical stocks are expected to draw keen attention from investors in the stock market, analysts said.
The expected passage of local pharmaceutical industry development act will boost Korean companies’ effort...
Hanmi releases simvastin CR tabletsHanmi Pharm said on February 2 that it has launched its new simvastin controlled-release (CR) 20 mg tablets, followed by its best-selling second simvastin series.
According t...
|
Kim Yoon-bin named as global partnership head of NITDNovartis Korea said that Kim Yoon-bin, Novartis’s venture fund manager, was appointed as head of Global Partnership, Novartis Institute for Tropical Diseases (NITD) as of Februa...
|
Yuhan outperforms Hanmi in sales
With disclosure of major pharmaceutical firms’ business performance last year in regulatory filings, Yuhan Corporation bulked up its market cap to 592.7 billion won last year, up 23.5 percent from the previous year, w...
Penzal series gaining less attention
Despite all-out promotion campaigns by Chong Kung Dang Pharmaceutical, its new Penzal Q and liquid preparations, which were launched in December, have been less pronouncing in pharmacy sales.
Sources say CKDP’s mar...
Redoxon Double Action is available at pharmacyBayer HealthCare says its newly launched Redoxon Double Action is available at pharmacy.
Redoxon Double Action is a powerful formula designed to help maintain your body's imm...
|
Pharmaceutical firms to launch first generic version of Stillen
Many major pharmaceutical manufacturers are rushing to introduce first generic versions of Dong-A’s Stillen, a homegrown medicine for treatment of gastric ulcer.
Chong Kun Dang Pharma will lead the first version la...
Downsizing sweeps drugmakers
A number of pharmaceutical firms are implementing massive restructuring measures as they look to respond to collapsed demand in the midst of the accelerating business slump.
With pharmaceutical firms cutting produc...
GSK benefits from Oracle's solution
GlaxoSmithKline says Oracle's Agile Product Lifecycle Management for Process (Agile PLM for Process) enables the company to shorten cycle times, increase sales, lower costs and reduce risks associated with innovation....
